Literature DB >> 15126592

MCL-1 promoter insertions dial-up aggressiveness of chronic leukemia.

Shinichi Kitada, John C Reed.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15126592     DOI: 10.1093/jnci/djh153

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  9 in total

1.  MCL-1 localizes to sites of DNA damage and regulates DNA damage response.

Authors:  Sarwat Jamil; Cezar Stoica; Tillie-Louise Hackett; Vincent Duronio
Journal:  Cell Cycle       Date:  2010-07-11       Impact factor: 4.534

2.  Expression of executioner procaspases and their activation by a procaspase-activating compound in chronic lymphocytic leukemia cells.

Authors:  Viralkumar Patel; Kumudha Balakrishnan; Michael J Keating; William G Wierda; Varsha Gandhi
Journal:  Blood       Date:  2014-12-23       Impact factor: 22.113

3.  Impact of bone marrow stromal cells on Bcl-2 family members in chronic lymphocytic leukemia.

Authors:  Viralkumar Patel; Lisa S Chen; William G Wierda; Kumudha Balakrishnan; Varsha Gandhi
Journal:  Leuk Lymphoma       Date:  2013-09-10

4.  FLT3-ITD up-regulates MCL-1 to promote survival of stem cells in acute myeloid leukemia via FLT3-ITD-specific STAT5 activation.

Authors:  Goichi Yoshimoto; Toshihiro Miyamoto; Siamak Jabbarzadeh-Tabrizi; Tadafumi Iino; Jennifer L Rocnik; Yoshikane Kikushige; Yasuo Mori; Takahiro Shima; Hiromi Iwasaki; Katsuto Takenaka; Koji Nagafuji; Shin-ichi Mizuno; Hiroaki Niiro; Gary D Gilliland; Koichi Akashi
Journal:  Blood       Date:  2009-10-06       Impact factor: 22.113

5.  A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy.

Authors:  W J Placzek; J Wei; S Kitada; D Zhai; J C Reed; M Pellecchia
Journal:  Cell Death Dis       Date:  2010-05-06       Impact factor: 8.469

6.  Mcl-1 is up regulated by prenylated coumarin, umbelliprenin in jurkat cells.

Authors:  Omid Gholami; Mahmood Jeddi-Tehrani; Mehrdad Iranshahi; Amir Hassan Zarnani; Seyed Ali Ziai
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

7.  hBfl-1/hNOXA Interaction Studies Provide New Insights on the Role of Bfl-1 in Cancer Cell Resistance and for the Design of Novel Anticancer Agents.

Authors:  Elisa Barile; Guya D Marconi; Surya K De; Carlo Baggio; Luca Gambini; Ahmed F Salem; Manoj K Kashyap; Januario E Castro; Thomas J Kipps; Maurizio Pellecchia
Journal:  ACS Chem Biol       Date:  2016-12-27       Impact factor: 5.100

8.  LTβR overexpression promotes plasma cell accumulation.

Authors:  Jessica A Kotov; Ying Xu; Nicholas D Carey; Jason G Cyster
Journal:  PLoS One       Date:  2022-08-04       Impact factor: 3.752

9.  Novel Biomarker Proteins in Chronic Lymphocytic Leukemia: Impact on Diagnosis, Prognosis and Treatment.

Authors:  Lee Admoni-Elisha; Itay Nakdimon; Anna Shteinfer; Tal Prezma; Tasleem Arif; Nir Arbel; Anna Melkov; Ori Zelichov; Itai Levi; Varda Shoshan-Barmatz
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.